AIOT expert panel endorses chemo-immunotherapy as a new standard in resectable stage II-III NSCLC
Read the article

University of Texas MD Anderson Cancer Center, Houston
Dr. Tina Cascone is an associate professor, multidisciplinary section chief, and director of translational research in the Department of Thoracic/Head and Neck Medical Oncology at MD Anderson Cancer Center in Houston, United States. Her physician-scientist program focuses on mechanisms of tumor response and resistance to immunotherapy in non-small cell lung cancer. She has led practice-changing neoadjuvant immunotherapy trials including NEOSTAR and CheckMate 77T, serves as an At-Large Director on the board of the Society for Immunotherapy of Cancer, and holds editorial roles at the Journal for ImmunoTherapy of Cancer and Cancer Immunology Research. She is a frequent speaker at major international thoracic oncology congresses.
Tina Cascone
Programme Roster